Uncovering Shared and Tissue-Specific Molecular Adaptations to Intermittent Fasting in Liver, Brain, and Muscle

  1. Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, Australia
  2. La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia
  3. Translational Biomedical Proteomics Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore
  4. Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
  5. La Trobe University-Proteomics and Metabolomics Platform (LTU-PMP), La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia
  6. Epigenes Australia Pty Ltd., Melbourne, Australia
  7. Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, United States
  8. Centre for Cardiovascular Biology and Disease Research, La Trobe Institute for Molecular Sciences, La Trobe University, Bundoora, Australia
  9. Baker Heart and Diabetes Institute, Melbourne, Australia
  10. The Paul Feder laboratory for Alzheimer’s disease research at the Mina and Everard Goodman Faculty of Life Sciences, and the Leslie and Susan Gonda Multidisciplinary Brain Research Center, Bar Ilan University, Ramat Gan, Israel
  11. Laboratory for Neuroimmunology in Health and Diseases, Center for Medical Research on Innovation and Translation, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China
  12. Department of Microbiology and Immunology, School of Medicine; Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China
  13. Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
  14. School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Rozalyn Anderson
    University of Wisconsin-Madison, Madison, United States of America
  • Senior Editor
    Christopher Huang
    University of Cambridge, Cambridge, United Kingdom

Reviewer #1 (Public review):

Summary:

In this study, the authors employed comprehensive proteomics and transcriptomics analysis to investigate the systemic and organ-specific adaptations to IF in males. They found that shared biological signaling processes were identified across tissues, suggesting unifying mechanisms linking metabolic changes to cellular communication, which revealed both conserved and tissue-specific responses by which IF may optimize energy utilization, enhance metabolic flexibility, and promote cellular resilience.

Strengths:

This study detected multiple organs, including the liver, brain, and muscle, and revealed both conserved and tissue-specific responses to IF.

Weaknesses:

(1) Why did the authors choose the liver, brain, and muscle, but not other organs such as the heart and kidney? The latter are proven to be the largest consumers of ketones, which is also changed in the IF treatment of this study.

(2) The proteomics and transcriptomics analyses were only performed at 4 months. However, a strong correlation between IF and the molecular adaptations should be time point-dependent.

(3) The context lacks a "discussion" section, which would detail the significance and weaknesses of the study.

(4) There is no confirmation for the proteomic and transcriptomic profiling. For example, the important changes in proteomics could be further identified by a Western blot.

Reviewer #2 (Public review):

Summary:

Fan and colleagues measure proteomics and transcriptomics in 3 organs (liver, skeletal muscle, cerebral cortex) from male C57BL/6 mice to investigate whether intermittent fasting (IF; 16h daily fasting over 4 months) produces systemic and organ-specific adaptations.

They find shared signaling pathways, certain metabolic changes, and organ-specific responses that suggest IF might affect energy utilization, metabolic flexibility, while promoting resilience at the cellular level.

Strengths:

The fact that there are 3 organs and 2 -omics approaches is a strength of this study.

Weaknesses:

The analytical approach of the data generated by the present study is not well posed, because it doesn't help to answer key questions implicit in the experimental design. Consequently, the paper, as it is for now, reads as a mere description of results and not a response to specific questions.

The presentation of the figures, the knowledge of the literature, and the inclusion of only one sex (male) are all weaknesses.

Reviewer #3 (Public review):

Summary:

Fan et al utilize large omics data sets to give an overview of proteomic and gene expression changes after 4 months of intermittent fasting (IF) in liver, muscle, and brain tissue. They describe common and distinct pathways altered under IF across tissues using different analysis approaches. The main conclusions presented are the variability in responses across tissues with IF. Some common pathways were observed, but there were notable distinctions between tissues.

Strengths:

(1) The IF study was well conducted and ran out to 4 months, which was a nice long-term design.

(2) The multiomics approach was solid, and additional integrative analysis was complementary to illustrate the differential pathways and interactions across tissues.

(3) The authors did not overstep their conclusions and imply an overreached mechanism.

Weaknesses:

The weaknesses, which are minor, include the use of only male mice and the early start (6 weeks) of the IF treatment. See specifics in the recommendations section.

Author response:

Reviewer #1 (Public review):

Summary:

In this study, the authors employed comprehensive proteomics and transcriptomics analysis to investigate the systemic and organ-specific adaptations to IF in males. They found that shared biological signaling processes were identified across tissues, suggesting unifying mechanisms linking metabolic changes to cellular communication, which revealed both conserved and tissue-specific responses by which IF may optimize energy utilization, enhance metabolic flexibility, and promote cellular resilience.

Strengths:

This study detected multiple organs, including the liver, brain, and muscle, and revealed both conserved and tissue-specific responses to IF.

We appreciate the recognition of the study’s strengths and the opportunity to clarify the points raised.

Weaknesses:

(1) Why did the authors choose the liver, brain, and muscle, but not other organs such as the heart and kidney? The latter are proven to be the largest consumers of ketones, which is also changed in the IF treatment of this study.

We agree that the heart and kidney are critical organs in ketone metabolism. Our selection of the liver, brain, and muscle was guided by their distinct metabolic functions and relevance to systemic energy balance, neuroplasticity, and locomotor activity, key domains influenced by intermittent fasting (IF). These tissues also offer complementary perspectives on central and peripheral adaptations to IF. Notably, we have previously examined the effects of IF on the heart (eLife 12:RP89214), and we fully acknowledge the importance of the kidney. We intend to include it in future studies to broaden the scope and deepen our understanding of IF-induced systemic responses.

(2) The proteomics and transcriptomics analyses were only performed at 4 months. However, a strong correlation between IF and the molecular adaptations should be time point-dependent.

We appreciate this insightful comment. The 4-month time point was selected to capture long-term adaptations to IF, beyond acute or transitional effects. While we acknowledge that molecular responses to IF are time-dependent, our goal in this study was to establish a foundational understanding of sustained systemic and tissue-specific changes. We fully agree that a longitudinal approach would provide deeper insights into the temporal dynamics of IF-induced adaptations. To address this, we are currently undertaking a comprehensive 2-year study that is specifically designed to explore these time-dependent effects in greater detail.

(3) The context lacks a "discussion" section, which would detail the significance and weaknesses of the study.

We appreciate this observation. The manuscript was originally structured to emphasize results and interpretation within each section, but we recognize that a dedicated discussion section would enhance clarity and contextual depth. In the revised version, we will add a comprehensive discussion section addressing broader implications, limitations, and future directions of the study.

(4) There is no confirmation for the proteomic and transcriptomic profiling. For example, the important changes in proteomics could be further identified by a Western blot.

We acknowledge the importance of orthogonal validation to support high-throughput findings. While our study primarily focused on uncovering systemic patterns through proteomic and transcriptomic profiling, we agree that targeted confirmation would strengthen the conclusions. To this end, we have included immunohistochemical validation of a key protein common to all three organs—Serpin A1C. Additionally, we are planning a dedicated follow-up study to expand functional validation of several key proteins identified in this manuscript, which will be pursued as a separate project.

Reviewer #2 (Public review):

Summary:

Fan and colleagues measure proteomics and transcriptomics in 3 organs (liver, skeletal muscle, cerebral cortex) from male C57BL/6 mice to investigate whether intermittent fasting (IF; 16h daily fasting over 4 months) produces systemic and organ-specific adaptations.

They find shared signaling pathways, certain metabolic changes, and organ-specific responses that suggest IF might affect energy utilization, metabolic flexibility, while promoting resilience at the cellular level.

Strengths:

The fact that there are 3 organs and 2 -omics approaches is a strength of this study.

We appreciate the reviewer’s recognition of the breadth of our study design. By integrating proteomics and transcriptomics across three metabolically distinct organs, we aimed to provide a comprehensive view of systemic and tissue-specific adaptations to IF. This multi-organ, multi-omics approach was central to uncovering both conserved and divergent biological responses.

Weaknesses:

(1) The analytical approach of the data generated by the present study is not well posed, because it doesn't help to answer key questions implicit in the experimental design. Consequently, the paper, as it is for now, reads as a mere description of results and not a response to specific questions.

We thank the reviewer for this important observation. Our initial aim was to establish a foundational atlas of molecular changes induced by IF across key organs. However, we recognize that clearer framing of the biological questions would enhance interpretability. In the revised manuscript, we will have restructured the introduction, results, and discussion to align more explicitly with specific hypotheses, particularly those related to energy metabolism, cellular resilience, and inter-organ signaling. We have also added targeted analyses and clarified how each dataset contributes to answering these questions.

(2) The presentation of the figures, the knowledge of the literature, and the inclusion of only one sex (male) are all weaknesses.

We appreciate this feedback and agree that these are important considerations. Regarding figure presentation, we will revise several figures for improved clarity, add more descriptive legends, and reorganize supplemental materials to better support the main findings. On the literature front, we will expand the discussion to include recent and relevant studies on IF, metabolic adaptation, and sex-specific responses. As for the use of only male mice, this was a deliberate choice to reduce hormonal variability and focus on establishing baseline molecular responses. We fully acknowledge the importance of sex as a biological variable and will soon be conducting studies in female mice to address this gap.

Reviewer #3 (Public review):

Summary:

Fan et al utilize large omics data sets to give an overview of proteomic and gene expression changes after 4 months of intermittent fasting (IF) in liver, muscle, and brain tissue. They describe common and distinct pathways altered under IF across tissues using different analysis approaches. The main conclusions presented are the variability in responses across tissues with IF. Some common pathways were observed, but there were notable distinctions between tissues.

Strengths:

(1) The IF study was well conducted and ran out to 4 months, which was a nice long-term design.

(2) The multiomics approach was solid, and additional integrative analysis was complementary to illustrate the differential pathways and interactions across tissues.

(3) The authors did not overstep their conclusions and imply an overreached mechanism.

We sincerely thank the reviewer for acknowledging the strengths of our study design and analytical approach. We aimed to strike a careful balance between comprehensive data generation and cautious interpretation, and we appreciate the recognition that our conclusions were appropriately framed within the scope of the data.

Weaknesses:

The weaknesses, which are minor, include the use of only male mice and the early start (6 weeks) of the IF treatment. See specifics in the recommendations section.

We appreciate the reviewer’s thoughtful comments. The decision to use male mice and initiate IF at 6 weeks was based on minimizing hormonal variability and capturing early adult metabolic programming. We acknowledge that sex and developmental timing are important biological variables. To address this, we are conducting parallel studies in female mice and evaluating IF initiated at later life stages. These follow-up investigations will help determine the extent to which sex and timing influence the molecular and physiological outcomes of IF.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation